Next Article in Journal
Associations between Moderate-to-Vigorous Physical Activity and Neighbourhood Recreational Facilities: The Features of the Facilities Matter
Next Article in Special Issue
Prevalence of Virulence Determinants and Antimicrobial Resistance among Commensal Escherichia coli Derived from Dairy and Beef Cattle
Previous Article in Journal
Importance of All Movement Behaviors in a 24 Hour Period for Overall Health
Previous Article in Special Issue
Resistance to Extended-Spectrum β-Lactamases in Salmonella from a Broiler Supply Chain
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Multiresistant Bacteria Isolated from Chicken Meat in Austria

1
Institute of Hygiene, Microbiology and Environmental Medicine, Medical University of Graz, Graz 8010, Austria
2
Animal Health Service of the Department of Veterinary Administration, Styrian Government, Graz 8010, Austria
*
Author to whom correspondence should be addressed.
Int. J. Environ. Res. Public Health 2014, 11(12), 12582-12593; https://doi.org/10.3390/ijerph111212582
Submission received: 15 October 2014 / Revised: 27 November 2014 / Accepted: 28 November 2014 / Published: 4 December 2014

Abstract

:
Multidrug resistant bacteria (MDR bacteria), such as extended spectrum beta-lactamase (ESBL) Enterobacteriaceae, methicillin resistant Staphylococcus aureus (MRSA), and vancomycin-resistant Enterococci (VRE), pose a challenge to the human health care system. In recent years, these MDR bacteria have been detected increasingly outside the hospital environment. Also the contamination of food with MDR bacteria, particularly of meat and meat products, is a concern. The aim of the study was to evaluate the occurrence of MDR bacteria in chicken meat on the Austrian market. For this study, 50 chicken meat samples were analysed. All samples originated from chickens slaughtered in Austrian slaughterhouses and were marked as produced in Austria. Samples were analysed for the presence of ESBL Enterobacteriaceae, methicillin resistant Staphylococci and VRE. Resistance genes of the isolated bacteria were characterised by PCR and sequencing. In the present study 26 ESBL producing E. coli, five mecA gene harbouring Staphylococci (but no MRSA), and four VRE were detected in chicken meat samples of Austrian origin. In 24 (48%) of the samples no ESBL Enterobacteriaceae, MRSA, methicillin resistant coagulase negative Staphylococcus (MRCNS) or VRE could be detected. None of the samples contained all three types of investigated multiresistant bacteria. In concordance to previous studies, CTX-M-1 and SHV-12 were the dominant ESBL genes.

1. Introduction

The clinically most relevant MDR bacteria are extended spectrum beta-lactamase (ESBL) Enterobacteriaceae and methicillin resistant Staphylococcus aureus (MRSA) and also, but less prevalently, vancomycin-resistant Enterococci (VRE). These three groups of resistant bacteria are not only present in the hospital environment, but also in farm animals, meat and meat products [1,2,3,4]. Therefore, the spread of multidrug resistant (MDR) bacteria outside the hospital environment has posed a serious problem over the last few years, and livestock breeding with a rather extensive use of antibiotics has become a possible source for multiresistant bacteria. As a consequence, one possible transmission route for MDR bacteria from animal to human being is food, especially meat and meat products [2,3,5].
ESBL Enterobacteriaceae are widespread in poultry farming, but were also detected in other farm animals and their meat products [3,6]. Just as with the spread of ESBL in the healthy human population E. coli is the most common organism here, but there are differences in strain types and ESBL gene dominance. E. coli MLST type ST131 and ESBL enzyme CTX-M-15, the predominant types in humans, are nearly absent in farm animals and food products. In contrast to the observations above, the animal dominant types CTX-M-1, SHV-12 and CTX-M-14 are commonly found in human infections [7,8]. The presence of ESBL genes on mobile genetic elements reduces the impact of the strain background on the spread of ESBL. This fact also complicates the search for resistance reservoirs [7,8,9].
In contrast to ESBL Enterobacteriaceae, MRSA show a clearer separation concerning strains of human and animal origin. Livestock-associated (LA)-MRSA are essentially adapted to animals [5,10]. Most of these LA-MRSA lack several virulence factors, like Panton-Valentine leucocidin (PVL) toxin or enterotoxins. Hence serious human infections with LA-MRSA are less frequent than infections caused by hospital acquired (HA)-MRSA or community associated (CA)-MRSA. Studies carried out in Austria reported that up to 8% of all isolated MRSA are LA-MRSA and 10%–20% can be assigned to CA-MRSA. The majority of LA-MRSA detected in humans are considered to be a colonization only (healthy carriers) but also serious infections have been reported [5,11,12,13,14]. The mecA gene, which is responsible for methicillin resistance, is located on SCCmec cassettes. These are mobile genetic elements responsible for the transfer of resistance genes, but with lower transfer frequency than plasmids or transposons carrying ESBL genes [15,16]. Those gene cassettes can also be part of the genome of coagulase-negative Staphylococci (CNS) species. Several studies indicate that, similar to MRSA, mecA harbouring CNS (MRCNS) have a reservoir in animal farming facilities and can also be found in meat products [17,18,19,20].
MRSA and vancomycin-resistant Enterococcus (VRE) are endemic in hospital settings and long-term care facilities, and the prevalence of colonization is increasing [21,22]. Enterococci are intestinal bacteria which colonize mammals, birds, reptiles and insects. Currently, nine different variants of vancomycin resistance genes have been described in Enterococci (vanA, B, C, D, E, G, L, M and N). VanA and vanB are the most clinically relevant types leading to many cases of colonization but only sporadic infections in hospitals. VRE are among the first documented antibiotic resistant bacteria with primary origin in animal farming. The rise of VRE was caused by the use of the glycopeptide avoparcin as a growth promoter, starting from 1975. After that it was used extensively, mainly in broiler and pig farming. But, as avoparcin confers cross resistance to vancomycin, the (mis)use of avoparcin resulted in the selection of VRE until it was finally banned in animal farming in the whole European Union in 1996. A study carried out in Denmark reported a decline from 80% to 5% in the occurrence of VRE isolated from broilers in the period from 1995 to 1998. In Central Europe the presence of VRE isolated from human patients is stable at the level of 1% since 2000. Several studies show local rates up to 15%. This seems to be more related to nosocomial outbreaks [23,24,25,26,27,28]. The aim of this study was to investigate the presence of ESBL Enterobacteriaceae, methicillin resistant Staphylococci (MRSA and MRCNS) and VRE in chicken meat products slaughtered in Austria and the determination of (genetic) characteristics of the isolated strains. Samples were taken from the four main supermarket chains and from local butchers, in order to get an impression of chicken meat contamination with MDR bacteria.

2. Material and Methods

2.1. Samples

In the course of this study 50 samples of chicken meat (chm-sample-1 to chm-sample-50) were analysed. All samples originated from chickens slaughtered in Austrian slaughterhouses and were marked as produced in Austria. From January to March 2012, fresh meat samples (without skin) from four different supermarket chains as well as butchers were bought in the city of Graz. The samples were transported to the laboratory in a cooling-box at 4 °C and the investigation process was started immediately after arrival in the laboratory.

2.2. Strain Isolation and Detection

The preparation of the food samples was done according to ISO 6887-2:2003 [29]. Two enrichment methods were chosen for ESBL and MRSA: the first with peptone broth, the second with thioglycolate bouillon. VRE enrichment was done with enterococcosel (Becton Dickinson Austria, Vienna, Austria). 25 g of the meat samples were randomly selected, mixed with 225 mL peptone broth 1% (Oxoid Ltd, Basingstoke, England) and homogenized in a Stomacher® 400 Lab Blender for two minutes. The solution was poured into an Erlenmeyer flask and enriched overnight (16 to 24 hours) in an incubator shaker (Innova 4000, New Brunswick Scientific, Enfield, USA) at 150 rpm at 37 °C. After that, a decimal dilution series from peptone broth and enterococcosel enrichment up to 10−3 was performed. 0.1mL from the appropriate dilution was inoculated on chromeIDTM ESBL (bioMérieux, Marcy-l’Etoile, France), chromeIDTM VRE (bioMérieux) and oxacillin resistance screening agar (OXA agar, Oxoid Ltd.). ChromeIDTM ESBL agar was incubated for 24 hours at 37 °C; chromeIDTM VRE and OXA agar for 48 h at 37 °C. Colonies were assessed as described in the manufacturer’s manual and identified with Vitek MS (bioMerieux) [30]. In the second enrichment method, 1 g of each meat sample was inoculated in 5 mL thioglycolate bouillon and incubated overnight (16 to 24 h) at 37 °C. A sterile cotton swab was dipped into the thioglycolate bouillon and inoculated on the selective agar plates mentioned above. Bacteria were identified as described above. ESBL-positive E. coli were confirmed by CLSI Screening and Confirmatory Tests [31]. Resistance to the glycopeptides vancomycin and teicoplanin was confirmed by Etest (bioMérieux) according to the manufacturer’s instructions.

2.3. Antimicrobial Susceptibility Testing

For all identified Enterobacteriaceae, Staphylococcus spp and Enterococcus spp susceptibility testing was performed as recommended by the European Committee on Antimicrobial Susceptibility testing (EUCAST). The inhibition zone diameters were interpreted according to EUCAST guidelines, except Enterobacteriaceae tested for tetracycline, chloramphenicol and nalidixic acid, which were evaluated in conformity with Clinical Laboratory Standards Institute (CLSI) guidelines. There a no interpretation guidelines for zone diameters of these three antibiotics according to EUCAST (23, 24).
For Enterobacteriaceae ampicillin (10 µg), amoxicillin/clavulanic acid (20 µg/10 µg), piperacillin/tazobactam (100 µg/10 µg), cefalexin (30 µg), cefuroxime (30 µg), cefoxitin (30 µg), cefotaxime (5 µg), ceftazidime (10 µg), cefepime (30 µg), gentamicin (10 µg), trimethoprim/sulfamethoxazole (1.25 µg/23.75 µg), ciprofloxacin (5 µg), moxifloxacin (5 µg), imipenem (10 µg), meropenem (10 µg), tetracycline (30 µg), nalidixic acid (30 µg) and chloramphenicol (30 µg) BD BBLTM, Sensi-DiscTM paper discs (Becton, Dickinson and Company, Sparks, MD, USA) were used. Antimicrobial susceptibility for Staphylococcus spp was tested with penicillin (1 µg), cefoxitin (30 µg), tetracycline (30 µg), erythromycin (15 µg), clindamycin (2 µg), norfloxacin (10 µg), gentamicin (10 µg), trimethoprim/sulfamethoxazole (1.25 µg/23.75 µg), fusidic acid (10 µg), rifampicin (5 µg), linezolid (10 µg) and mupirocin (200 µg) BD BBLTM Sensi-DiscTM paper discs. Antimicrobial susceptibility for Enterococcus spp was determined for ampicillin (2 µg), vancomycin (5 µg), teicoplanin (30 µg), linezolid (10 µg) and tigecycline (15 µg) by disc diffusion test, using BD BBLTM Sensi-DiscTM paper discs, according the EUCAST guidelines (V2.0 2012).

2.4. Detection of Resistance Genes

PCR detection and gene identification were carried out for three different β-lactamase gene families, blaTEM, blaSHV and blaCTX-M (including subgroup 1, 2 and 9). PCR and sequencing procedures were performed as described previously [32,33]. Conditions for PCR: initial denaturation at 94 °C for 5 min; 35 cycles at 95 °C for 30 s, 52 °C for 45 s, and 72 °C for 60 s; and final incubation for 10 min at 72 °C. Taq DNA polymerase and dNTPs from QIAGEN (Hilden, Germany) were used. Sequences were compared to NCBI database. The detection of the mecA genes was performed as described previously [34] and the detection of the vancomycin resistance genes (vanA/vanB) was performed by real time PCR with the Light cycler VRE Detection Kit (Roche, Branchburg, New Jersey, USA) [35].

3. Results

3.1. ESBL Enterobacteriaceae

In 21 samples 26 different ESBL E. coli were detected; no other ESBL positive Enterobacteriaceae species were recovered. In five samples two phenotypically and genotypically different ESBL E. coli could be isolated. Three different ESBL genes were responsible for (ESBL) resistance in these isolates: Twelve isolates had genes encoding for CTX-M-1 enzyme, twelve for SHV-12 and two for SHV-2. The gene for non ESBL TEM-1 enzyme was also detected in three strains (two times in combination with CTX-M-1 and one time with SHV-12) (Table 1).
Table 1. Resistance genes and antibiotic resistance profile of multiresistant bacteria isolated from chicken meat.
Table 1. Resistance genes and antibiotic resistance profile of multiresistant bacteria isolated from chicken meat.
IsolateSpeciesResistance GeneSampleResistance Pattern
ESBL-1E. coliblaSHV-12chm-sample-1caz, tet, na, c
ESBL-2E. coliblaCTX-m-1chm-sample-1fep, tet, na, c
ESBL-3E. coliblaSHV-12chm-sample-2caz, fox, sxt, tet,na,c
ESBL-4E. coliblaCTX-m-1chm-sample-3fep, tet,na
ESBL-5E. coliblaCTX-m-1chm-sample-9tet,na
ESBL-6E. coliblaSHV-12chm-sample-9caz, tet,c
ESBL-7E. coliblaCTX-m-1chm-sample-10fep, tet
ESBL-8E. coliblaSHV-12chm-sample-16caz, tet, c
ESBL-9E. coliblaCTX-m-1, blaTEM-1chm-sample-17fep, sxt, tet, c
ESBL-10E. coliblaSHV-12chm-sample-19caz, tet, na, c
ESBL-11E. coliblaCTX-m-1chm-sample-21fep, fox, tet, na, c
ESBL-12E. coliblaSHV-12, blaTEM-1chm-sample-21caz, mxf, tet, na, c
ESBL-13E. coliblaSHV-12chm-sample-22caz, tet, na, c
ESBL-14E. coliblaCTX-m-1chm-sample-25tet, na
ESBL-15E. coliblaSHV-12chm-sample-28caz, tet, na, c
ESBL-16E. coliblaSHV-2chm-sample-33na
ESBL-17E. coliblaCTX-m-1chm-sample-34fep, tet
ESBL-18E. coliblaCTX-m-1chm-sample-36fep, tet
ESBL-19E. coliblaCTX-m-1chm-sample-39fep, sxt, tet, na
ESBL-20E. coliblaCTX-m-1, blaTEM-1chm-sample-39tet
ESBL-21E. coliblaSHV-2chm-sample-40sxt, tet, na
ESBL-22E. coliblaSHV-12chm-sample-43caz, tet, na
ESBL-23E. coliblaCTX-m-1chm-sample-44fep, na
ESBL-24E. coliblaSHV-12chm-sample-44caz
ESBL-25E. coliblaSHV-12chm-sample-45caz, tet, na, c
ESBL-26E. coliblaSHV-12chm-sample-50caz, tet, na
VRE-1E. faeciumvanAchm-sample-17am, tec
VRE-2E. faeciumvanAchm-sample-23tec
VRE-3E. faeciumvanAchm-sample-33am, tec
VRE-4E. faeciumvanA, vanBchm-sample-33am
MRCNS-1Staph. fleurettiimecAchm-sample-9
MRCNS-2Staph. sciurimecAchm-sample-11
MRCNS-3Staph. sciurimecAchm-sample-16
MRCNS-4Staph. vitulinusmecAchm-sample-18
MRCNS-5Staph. vitulinusmecAchm-sample-49
All isolates were susceptible to the tested aminoglycosides, β-lactam/β-lactamase inhibitor, carbapenems, ciprofloxacin and tigecycline. Highest resistance rates were observed for tetracycline in 23 (88.46%) of the isolates and nalidixic acid in 18 (78.26%) isolates. All isolates were resistant against the third generation cephalosporine cefotaxime. In addition, the SHV-12 positive isolates (46.15% of isolated ESBL E. coli) showed non-susceptibility to third generation ceftazidime (10 µg). Nine isolates (34.61%), all positive for the CTX-M-1 gene, were resistant against the fourth generation cephalosporin cefepime (Table 1).

3.2. MRSA and MRCNS

All samples were tested negative for MRSA. However, five coagulase negative Staphylococcus strains, recovered from MRSA screening Agar, were positive for the mecA gene (10 % of the samples). They were identified as Staphylococcus vitulinus (two), Staphylococcus sciuri (two) and Staphylococcus fleurettii (one) (Table 1). Beside resistance to penicillin and cefoxitin, none of these strains showed additional resistance.

3.3. VRE

VRE were found in three of 50 samples (6%). A total of four Enterococcus strains, different in their van genes, were recovered and analysed in detail. All isolates were identified as Enterococcus faecium and harboured the vanA gen whereas one isolate (VRE-4) was additionally vanB positive. All isolates showed highly similar resistance patterns. They were all resistant to vancomycin, and susceptible to tigecycline and linezolid. Only one isolate was susceptible to teicoplanin (VRE-4) and one to amoxicillin (VRE-2) (Table 1).

4. Discussion

Besides the international trade of farm animals, intensive antibiotic use is an important factor for the spread of livestock-associated, multiresistant bacteria. Presence of E. coli ESBL in poultry and poultry meat products is documented by many studies from all over the world. High contamination rates with ESBL Enterobacteriaceae, up to 93.3%, are reported [6,36,37]. Austria and surrounding countries do not seem to observe such high rates of MDR bacteria in meat although in some cases such as in Austria, data are extremely limited. The study from 2012 Springer and Bruckner with samples from 2009 revealed a little lower ESBL frequency (35.9% of chicken meat samples) but with a very low SHV frequency [38]. In contrast, recent German studies by Campos et al. [39] and Kola et al. [40] detected SHV-12 as second or most common ESBL enzymes in poultry meat. Frequencies of total ESBL E. coli in these two studies were similar (Kola et al. 43.9% samples from 2011) or higher (Campos et al. 60% samples from 2012).
Therefore the results of the present study concerning SHV-12 and CTX-M-1 are in concordance with those of other European countries. Both genes are very common in animal farming. SHV-12 is known to be associated mainly with poultry and CTX-M-1 is widespread in mammals. In contrast to other studies, TEM-52 and CTX-M-14, also common in farm animals and meat products, were not detected here [36,37,39,40]. Two reasons for the absence of these genes might be the relatively small sample size and the exclusive Austrian origin of the poultry.
In concordance with previous studies, the resistance against tetracycline is shown to be common in farm animals and meat product samples because tetracycline is known to be still in use in livestock breeding. In contrast to this, in the present study fluoroquinolone resistance was nearly absent, although fluoroquinolones are frequently used antibiotics in human healthcare in Austria. This finding can not only be explained with the connection of this resistance to the occurrence of CTX-M-15 because reports from non-CTX-M-15 ESBL E. coli from Austria show that fluoroquinolone resistance is present in human and also environmental isolates [7,38,41,42,43].
LA-MRSA are known to be associated essentially with mammalian farm animals but was also isolated from poultry and poultry meat products. Contamination of meat with HA- or CA-MRSA, possibly caused due to the lack of hygiene during meat production, is also documented. Hence the absence of MRSA in this study was surprising [44,45,46]. But the mecA gene was present in coagulase negative Staphylococci in animal farming years before the first LA-MRSA was reported. The detected MRCNS species in this study are also in concordance with previous studies [47,48,49]. Although avoparcin was banned in animal feeding in the European Union more than two decades ago, VRE are still present in the meat production. The persistence of VRE over a prolonged time period is potentially caused by co-selection with other food additives [24,25,50].

5. Conclusions

ESBL E. coli was the most common type of multiresistant bacteria observed in this study. Testing revealed 21 samples out of 50 (42%) as positive for ESBL. No MRSA could be detected but five samples were positive for MRCNS. VRE could be recovered from three samples (6%). None of the samples contained all three types of multiresistant bacteria, but three samples harboured E. coli ESBL together with MRCNS, and in two samples E. coli ESBL emerged additionally to VRE. In 24 (48%) samples no ESBL Enterobacteriaceae, MRSA, MRCNS or VRE could be detected. This study had a very limited sample size, and thus limited power to infer the prevalence of antimicrobial resistance in chicken meat in Austria. Although informative as a starting point, especially considering the lack of Austrian data, further work on this matter in Austria should occur.

Acknowledgments

Funding Sources. This project was funded by “Hygienefonds der Medizinischen Universität Graz”, Auenbruggerplatz 2, 8010 Graz, Austria.

Author Contributions

Gernot Zarfel, Herbert Galler, Gebhard Feierl, and Franz F. Reinthaler conceptualized the manuscript’s focus and analyses. Peter Pless took samples and provided background information of samples. Herbert Galler, Christian Petternel and Josefa Luxner performed the bacterial isolation, microbiological experiments, and analyses. Gernot Zarfel and Josefa Luxner performed molecular biology experiments. Clemens Kittinger, Doris Haas, and Andrea J. Grisold edited the manuscript.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Holzel, C.S.; Schwaiger, K.; Harms, K.; Kuchenhoff, H.; Kunz, A.; Meyer, K.; Muller, C.; Bauer, J. Sewage sludge and liquid pig manure as possible sources of antibiotic resistant bacteria. Environ. Res. 2010, 110, 318–326. [Google Scholar] [CrossRef] [PubMed]
  2. Ghidan, A.; Dobay, O.; Kaszanyitzky, E.J.; Samu, P.; Amyes, S.G.B.; Nagy, K.; Rozgonyi, F. Vancomycin resistant Enterococci (Vre) still persist in slaughtered poultry in Hungary 8 years after the ban on Avoparcin. Acta Microbiol. Immunol. Hung. 2008, 55, 409–417. [Google Scholar] [CrossRef] [PubMed]
  3. Carattoli, A. Animal reservoirs for extended spectrum beta-lactamase producers. Clin. Microbiol. Infect. 2008, 14, 117–123. [Google Scholar] [CrossRef] [PubMed]
  4. Springer, B.; Orendi, U.; Much, P.; Hoger, G.; Ruppitsch, W.; Krziwanek, K.; Metz-Gercek, S.; Mittermayer, H. Methicillin-resistant Staphylococcus aureus: A new zoonotic agent? Wien. Klin. Wochenschr. 2009, 121, 86–90. [Google Scholar] [CrossRef] [PubMed]
  5. Van Cleef, B.A.; Monnet, D.L.; Voss, A.; Krziwanek, K.; Allerberger, F.; Struelens, M.; Zemlickova, H.; Skov, R.L.; Vuopio-Varkila, J.; Cuny, C.; et al. Livestock-associated methicillin-resistant Staphylococcus aureus in humans, Europe. Emerg. Infect. Dis. 2011, 17, 502–505. [Google Scholar]
  6. Doi, Y.; Paterson, D.L.; Egea, P.; Pascual, A.; Lopez-Cerero, L.; Navarro, M.D.; Adams-Haduch, J.M.; Qureshi, Z.A.; Sidjabat, H.E.; Rodriguez-Bano, J. Extended-spectrum and CMY-Type beta-lactamase-producing Escherichia coli in clinical samples and retail meat from Pittsburgh, USA and Seville, Spain. Clin. Microbiol. Infect. 2010, 16, 33–38. [Google Scholar] [CrossRef] [PubMed]
  7. Livermore, D.M.; Canton, R.; Gniadkowski, M.; Nordmann, P.; Rossolini, G.M.; Arlet, G.; Ayala, J.; Coque, T.M.; Kern-Zdanowicz, I.; Luzzaro, F.; et al. CTX-M: Changing the face of ESBLs in Europe. J. Antimicrob. Chemother. 2007, 59, 165–174. [Google Scholar] [CrossRef]
  8. Paterson, D.L. Resistance in gram-negative bacteria: Enterobacteriaceae. Am. J. Infect. Control 2006, 34, S20–S28, S64–S73. [Google Scholar] [CrossRef]
  9. Woodford, N.; Carattoli, A.; Karisik, E.; Underwood, A.; Ellington, M.J.; Livermore, D.M. Complete nucleotide sequences of plasmids pEK204, pEK499, and pEK516, encoding CTX-M enzymes in three major Escherichia coli lineages from the United Kingdom, all belonging to the international O25:H4-ST131 clone. Antimicrob. Agents Chemother. 2009, 53, 4472–4482. [Google Scholar] [CrossRef] [PubMed]
  10. Huijsdens, X.W.; van Dijke, B.J.; Spalburg, E.; van Santen-Verheuvel, M.G.; Heck, M.E.; Pluister, G.N.; Voss, A.; Wannet, W.J.; de Neeling, A.J. Community-acquired MRSA and pig-farming. Ann. Clin. Microbiol. Antimicrob. 2006, 5. [Google Scholar] [CrossRef] [Green Version]
  11. Luxner, J.; Zarfel, G.; Johler, S.; Feierl, G.; Leitner, E.; Hoenigl, M.; Grisold, A.J. Genetic characterization of Staphylococcus aureus isolates causing bloodstream infections in Austria. Diagn. Microbiol. Infect. Dis. 2014, 78, 153–156. [Google Scholar] [CrossRef] [PubMed]
  12. Zarfel, G.; Krziwanek, K.; Johler, S.; Hoenigl, M.; Leitner, E.; Kittinger, C.; Masoud, L.; Feierl, G.; Grisold, A.J. Virulence and antimicrobial resistance genes in human MRSA ST398 isolates in Austria. Epidemiol. Infect. 2013, 141, 888–892. [Google Scholar] [CrossRef] [PubMed]
  13. Grisold, A.J.; Zarfel, G.; Stoeger, A.; Feierl, G.; Raggam, R.B.; Marth, E. Emergence of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) in Southeast Austria. J. Infect. 2009, 58, 168–170. [Google Scholar] [CrossRef] [PubMed]
  14. Krziwanek, K.; Luger, C.; Sammer, B.; Stumvoll, S.; Stammler, M.; Sagel, U.; Witte, W.; Mittermayer, H. MRSA in Austria—An overview. Clin. Microbiol. Infect. 2008, 14, 250–259. [Google Scholar] [CrossRef] [PubMed]
  15. Shore, A.C.; Coleman, D.C. Staphylococcal cassette chromosome mec: Recent advances and new insights. Int. J. Med. Microbiol. 2013, 303, 350–359. [Google Scholar] [CrossRef] [PubMed]
  16. Scharn, C.R.; Tenover, F.C.; Goering, R.V. Transduction of Staphylococcal cassette chromosome mec elements between strains of Staphylococcus aureus. Antimicrob. Agents Chemother. 2013, 57, 5233–5238. [Google Scholar] [CrossRef] [PubMed]
  17. Nemeghaire, S.; Argudin, M.A.; Haesebrouck, F.; Butaye, P. Molecular epidemiology of methicillin-resistant Staphylococcus sciuri in healthy chickens. Vet. Microbiol. 2014, 171, 357–363. [Google Scholar] [CrossRef] [PubMed]
  18. Tsubakishita, S.; Kuwahara-Arai, K.; Sasaki, T.; Hiramatsu, K. Origin and molecular evolution of the determinant of methicillin resistance in Staphylococci. Antimicrob. Agents Chemother. 2010, 54, 4352–4359. [Google Scholar] [CrossRef] [PubMed]
  19. Tulinski, P.; Fluit, A.C.; Wagenaar, J.A.; Mevius, D.; van de Vijver, L.; Duim, B. Methicillin-resistant coagulase-negative Staphylococci on pig farms as a reservoir of heterogeneous Staphylococcal cassette chromosome mec elements. Appl. Environ. Microbiol. 2012, 78, 299–304. [Google Scholar] [CrossRef] [PubMed]
  20. Landeta, G.; Curiel, J.A.; Carrascosa, A.V.; Munoz, R.; de las Rivas, B. Characterization of coagulase-negative Staphylococci isolated from Spanish dry cured meat products. Meat Sci. 2013, 93, 387–396. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  21. Shenoy, E.S.; Paras, M.L.; Noubary, F.; Walensky, R.P.; Hooper, D.C. Natural history of colonization with methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus (VRE): A systematic review. BMC Infect. Dis. 2014, 14. [Google Scholar] [CrossRef] [PubMed]
  22. Gastmeier, P.; Schroder, C.; Behnke, M.; Meyer, E.; Geffers, C. Dramatic increase in vancomycin-resistant Enterococci in Germany. J. Antimicrob. Chemother. 2014, 69, 1660–1664. [Google Scholar] [CrossRef] [PubMed]
  23. Bager, F.; Madsen, M.; Christensen, J.; Aarestrup, F.M. Avoparcin used as a growth promoter is associated with the occurrence of vancomycin-resistant Enterococcus faecium on Danish poultry and pig farms. Prev. Vet. Med. 1997, 31, 95–112. [Google Scholar] [CrossRef] [PubMed]
  24. Nilsson, O. Vancomycin resistant Enterococci in farm animals—Occurrence and importance. Infect. Ecol. Epidemiol. 2012, 2. [Google Scholar] [CrossRef]
  25. Hammerum, A.M.; Lester, C.H.; Heuer, O.E. Antimicrobial-resistant Enterococci in animals and meat: A human health hazard? Foodborne Pathog. Dis. 2010, 7, 1137–1146. [Google Scholar] [CrossRef] [PubMed]
  26. Mutters, N.T.; Mersch-Sundermann, V.; Mutters, R.; Brandt, C.; Schneider-Brachert, W.; Frank, U. Control of the spread of vancomycin-resistant Enterococci in hospitals: Epidemiology and clinical relevance. Dtsch. Arztebl Int. 2013, 110, 725–731. [Google Scholar] [PubMed]
  27. Werner, G.; Coque, T.M.; Hammerum, A.M.; Hope, R.; Hryniewicz, W.; Johnson, A.; Klare, I.; Kristinsson, K.G.; Leclercq, R.; Lester, C.H.; et al. Emergence and spread of vancomycin resistance among Enterococci in Europe. Euro Surveill. 2008, 13. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19046 (accessed on 20 November 2008).
  28. Aarestrup, F.M. Characterization of glycopeptide-resistant Enterococcus faecium (GRE) from broilers and pigs in Denmark: Genetic evidence that persistence of GRE in pig herds is associated with coselection by resistance to macrolides. J. Clin. Microbiol. 2000, 38, 2774–2777. [Google Scholar] [PubMed]
  29. ISO 6887-2:2003. Available online: http://www.iso.org/iso/catalogue_detail.htm?csnumber=29866 (accessed on 15 October 2014).
  30. Martiny, D.; Busson, L.; Wybo, I.; El Haj, R.A.; Dediste, A.; Vandenberg, O. Comparison of the microflex LT and vitek MS systems for routine identification of bacteria by matrix-assisted laser desorption ionization-time of flight mass spectrometry. J. Clin. Microbiol. 2012, 50, 1313–1325. [Google Scholar] [CrossRef] [PubMed]
  31. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Informational Supplement. CLSI Document M100-S18; Clinical and Laboratory Standards Institute: Wayne, PA, USA, 2008. [Google Scholar]
  32. Kiratisin, P.; Apisarnthanarak, A.; Laesripa, C.; Saifon, P. Molecular characterization and epidemiology of extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates causing health, care-associated infection in Thailand, where the CTX-M family is endemic. Antimicrob. Agents Chemother. 2008, 52, 2818–2824. [Google Scholar] [CrossRef] [PubMed]
  33. Eckert, C.; Gautier, V.; Saladin-Allard, M.; Hidri, N.; Verdet, C.; Ould-Hocine, Z.; Barnaud, G.; Delisle, F.; Rossier, A.; Lambert, T.; et al. Dissemination of CTX-M-Type beta-lactamases among clinical isolates of Enterobacteriaceae in Paris, France. Antimicrob. Agents Chemother. 2004, 48, 1249–1255. [Google Scholar] [CrossRef]
  34. Grisold, A.J.; Kessler, H.H. Use of hybridization probes in a real-time PCR assay on the lightcycler for the detection of methicillin-resistant Staphylococcus aureus. Methods Mol. Biol. 2006, 345, 79–89. [Google Scholar] [PubMed]
  35. Koh, T.H.; Deepak, R.N.; Se-Thoe, S.Y.; Lin, R.V.; Koay, E.S. Experience with the roche lightcycler VRE detection kit during a large outbreak of vanB2/B3 vancomycin-resistant Enterococcus faecium. J. Antimicrob. Chemother. 2007, 60, 182–183. [Google Scholar] [CrossRef] [PubMed]
  36. Overdevest, I.; Willemsen, I.; Rijnsburger, M.; Eustace, A.; Xu, L.; Hawkey, P.; Heck, M.; Savelkoul, P.; Vandenbroucke-Grauls, C.; van der Zwaluw, K.; et al. Extended-spectrum beta-lactamase genes of Escherichia coli in chicken meat and humans, the Netherlands. Emerg. Infect. Dis. 2011, 17, 1216–1222. [Google Scholar] [CrossRef]
  37. Egea, P.; Lopez-Cerero, L.; Torres, E.; Gomez-Sanchez Mdel, C.; Serrano, L.; Navarro Sanchez-Ortiz, M.D.; Rodriguez-Bano, J.; Pascual, A. Increased raw poultry meat colonization by extended spectrum beta-lactamase-producing Escherichia coli in the south of Spain. Int. J. Food Microbiol. 2012, 159, 69–73. [Google Scholar] [CrossRef] [PubMed]
  38. Springer, B.; Bruckner, K. Characterization of extended-spectrum beta-lactamase (ESBL) producing Escherichia coli from raw meat and comparison to human isolates. Wien Tierarztl Monatsschr. 2012, 99, 44–50. [Google Scholar]
  39. Belmar Campos, C.; Fenner, I.; Wiese, N.; Lensing, C.; Christner, M.; Rohde, H.; Aepfelbacher, M.; Fenner, T.; Hentschke, M. Prevalence and genotypes of extended spectrum beta-lactamases in Enterobacteriaceae isolated from human stool and chicken meat in Hamburg, Germany. Int. J. Med. Microbiol. 2014, 304, 678–684. [Google Scholar] [CrossRef] [PubMed]
  40. Kola, A.; Kohler, C.; Pfeifer, Y.; Schwab, F.; Kuhn, K.; Schulz, K.; Balau, V.; Breitbach, K.; Bast, A.; Witte, W.; et al. High prevalence of extended-spectrum-beta-lactamase-producing Enterobacteriaceae in organic and conventional retail chicken meat, Germany. J. Antimicrob. Chemother. 2012, 67, 2631–2634. [Google Scholar] [CrossRef] [PubMed]
  41. Zarfel, G.; Galler, H.; Feierl, G.; Haas, D.; Kittinger, C.; Leitner, E.; Grisold, A.J.; Mascher, F.; Posch, J.; Pertschy, B.; et al. Comparison of extended-spectrum-beta-lactamase (ESBL) carrying Escherichia coli from sewage sludge and human urinary tract infection. Environ. Pollut. 2013, 173, 192–199. [Google Scholar] [CrossRef] [PubMed]
  42. Petternel, C.; Galler, H.; Zarfel, G.; Luxner, J.; Haas, D.; Grisold, A.J.; Reinthaler, F.F.; Feierl, G. Isolation and characterization of multidrug-resistant bacteria from minced meat in Austria. Food Microbiol. 2014, 44, 41–46. [Google Scholar] [CrossRef] [PubMed]
  43. Garcia-Migura, L.; Hendriksen, R.S.; Fraile, L.; Aarestrup, F.M. Antimicrobial resistance of zoonotic and commensal bacteria in Europe: The missing link between consumption and resistance in veterinary medicine. Vet. Microbiol. 2014, 170, 1–9. [Google Scholar] [CrossRef] [PubMed]
  44. Fessler, A.T.; Kadlec, K.; Hassel, M.; Hauschild, T.; Eidam, C.; Ehricht, R.; Monecke, S.; Schwarz, S. Characterization of methicillin-resistant Staphylococcus aureus isolates from food and food products of poultry origin in Germany. Appl. Environ. Microbiol. 2011, 77, 7151–7157. [Google Scholar] [CrossRef] [PubMed]
  45. Lozano, C.; Lopez, M.; Gomez-Sanz, E.; Ruiz-Larrea, F.; Torres, C.; Zarazaga, M. Detection of methicillin-resistant Staphylococcus aureus ST398 in food samples of animal origin in Spain. J. Antimicrob. Chemother. 2009, 64, 1325–1326. [Google Scholar] [CrossRef] [PubMed]
  46. Nemeghaire, S.; Roelandt, S.; Argudin, M.A.; Haesebrouck, F.; Butaye, P. Characterization of methicillin-resistant Staphylococcus aureus from healthy carrier chickens. Avian Pathol. 2013, 42, 342–346. [Google Scholar] [CrossRef] [PubMed]
  47. Kawano, J.; Shimizu, A.; Saitoh, Y.; Yagi, M.; Saito, T.; Okamoto, R. Isolation of methicillin-resistant coagulase-negative Staphylococci from chickens. J. Clin. Microbiol. 1996, 34, 2072–2077. [Google Scholar] [PubMed]
  48. Huber, H.; Ziegler, D.; Pfluger, V.; Vogel, G.; Zweifel, C.; Stephan, R. Prevalence and characteristics of methicillin-resistant coagulase-negative Staphylococci from livestock, chicken carcasses, bulk tank milk, minced meat, and contact persons. BMC Vet. Res. 2011, 7. [Google Scholar] [CrossRef] [Green Version]
  49. Bhargava, K.; Zhang, Y. Characterization of methicillin-resistant coagulase-negative Staphylococci (MRCoNS) in retail meat. Food Microbiol. 2014, 42, 56–60. [Google Scholar] [CrossRef] [PubMed]
  50. Sting, R.; Richter, A.; Popp, C.; Hafez, H.M. Occurrence of vancomycin-resistant Enterococci in turkey flocks. Poult. Sci. 2013, 92, 346–351. [Google Scholar] [CrossRef] [PubMed]

Share and Cite

MDPI and ACS Style

Zarfel, G.; Galler, H.; Luxner, J.; Petternel, C.; Reinthaler, F.F.; Haas, D.; Kittinger, C.; Grisold, A.J.; Pless, P.; Feierl, G. Multiresistant Bacteria Isolated from Chicken Meat in Austria. Int. J. Environ. Res. Public Health 2014, 11, 12582-12593. https://doi.org/10.3390/ijerph111212582

AMA Style

Zarfel G, Galler H, Luxner J, Petternel C, Reinthaler FF, Haas D, Kittinger C, Grisold AJ, Pless P, Feierl G. Multiresistant Bacteria Isolated from Chicken Meat in Austria. International Journal of Environmental Research and Public Health. 2014; 11(12):12582-12593. https://doi.org/10.3390/ijerph111212582

Chicago/Turabian Style

Zarfel, Gernot, Herbert Galler, Josefa Luxner, Christian Petternel, Franz F. Reinthaler, Doris Haas, Clemens Kittinger, Andrea J. Grisold, Peter Pless, and Gebhard Feierl. 2014. "Multiresistant Bacteria Isolated from Chicken Meat in Austria" International Journal of Environmental Research and Public Health 11, no. 12: 12582-12593. https://doi.org/10.3390/ijerph111212582

Article Metrics

Back to TopTop